Evidence map›Paper›PMID 41657567›Full record

ArticleFrontiers in medicine2025

Evaluating deep learning-based image segmentation for radiotherapy planning in pelvic and abdominal cancers.

Xuejiao Chen, Shuo Lai

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xuejiao ChenDepartment of Oncology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Shuo LaiMedical School, Shanghai Normal University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The integration of artificial intelligence (AI) into radiotherapy planning for pelvic and abdominal malignancies has ushered in a new era of precision oncology, enhancing treatment accuracy and patient outcomes. Central to this advancement is the development of sophisticated image segmentation techniques that accurately delineate tumors and surrounding organs at risk. Traditional segmentation methods, often reliant on manual contouring or basic algorithmic approaches, are time-consuming and susceptible to inter-operator variability, potentially compromising treatment efficacy. Moreover, existing deep learning models, while promising, frequently struggle with challenges such as ambiguous anatomical boundaries, small or disconnected lesion regions, and underrepresented classes within training datasets. Methods: To address these challenges, research has progressively evolved from rigid anatomical modeling to more flexible, learning-based paradigms capable of adapting to diverse clinical presentations. However, even with the advent of advanced deep neural networks like U-Net and its variants, segmentation models often face difficulties in generalizing across multi-center datasets due to variability in imaging protocols and anatomical diversity. Furthermore, high computational demands and a lack of interpretability continue to hinder seamless clinical integration. Results and discussion: In this study, we propose an attention-enhanced domain-adaptive segmentation framework tailored for radiotherapy planning in complex anatomical regions. By incorporating a context-aware attention mechanism and a fine-tuned adaptation module, our method aims to achieve high segmentation accuracy while maintaining computational efficiency. This framework not only improves performance on heterogeneous data but also facilitates robust and reproducible contouring of organs and lesions, contributing to more effective and individualized radiation therapy planning.

Indexed as

artificial intelligencedeep learningimage segmentationpelvic and abdominal cancersradiotherapy planning

Identifiers

PMID41657567
PMCPMC12872535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.